877-202-0205     support@chemchart.com     @chemchart
        
Sign In    Register
   Reset Filters

Polycyclic organic compounds, Experimental cancer drugs, matrixscientific.com, Three-membered rings, Antineoplastic and immunomodulating drugs

Categories

Antineoplastic drugs (1)
Cyclic compounds (1)
Cycloalkanes (1)
Cyclopropanes (1)
Halides (1)
Organofluorides (1)
Organohalides (1)
Pharmaceuticals (1)
Piperazines (1)
Six-membered rings (1)
Tetracyclic compounds (1)

Zosuquidar Trihydrochloride (167465-36-3)  
Zosuquidar (also LY-335979) is an experimental antineoplastic drug. In 2010, it was announced that a phase III trial for the treatment of acute myeloid leukemia (AML) and myelodysplastic syndrome did not meet its primary endpoint and Eli Lilly discontinued its development. Zosquidir inhibits P-glycoproteins.
Related searches
Polycyclic organic compounds
Experimental cancer drugs
matrixscientific.com
Three-membered rings
Antineoplastic and immunomodulating drugs